Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

Very few data exist on when a particular thrombopoietin-receptor agonist (TPO-RA) is favored in clinical practice for the treatment of patients with immune thrombocytopenia (ITP), about novel risk factors for vascular events (VE) with these drugs, nor about predictive factors for therapy free respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano, Maria L., Mingot-Castellano, Maria E., Perera, María M., Jarque, Isidro, Campos-Alvarez, Rosa M., González-López, Tomás J., Carreño-Tarragona, Gonzalo, Bermejo, Nuria, Lopez-Fernandez, Maria F., de Andrés, Aurora, Valcarcel, David, Casado-Montero, Luis F., Alvarez-Roman, Maria T., Orts, María I., Novelli, Silvana, Revilla, Nuria, González-Porras, Jose R., Bolaños, Estefanía, Rodríguez-López, Manuel A., Orna-Montero, Elisa, Vicente, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853922/
https://www.ncbi.nlm.nih.gov/pubmed/31723222
http://dx.doi.org/10.1038/s41598-019-53209-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853922/
https://www.ncbi.nlm.nih.gov/pubmed/31723222
http://dx.doi.org/10.1038/s41598-019-53209-y

Ejemplares similares